Titan Pharmaceuticals
TTNP
#10335
Rank
NZ$10.24 M
Marketcap
NZ$7.70
Share price
-3.76%
Change (1 day)
8.39%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$7.87 Million, an increase over its 2023 earnings that were of -NZ$9.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-39.87%
2024 -NZ$7.87 Million-15.5%
2023 -NZ$9.31 Million-45.43%
2022 -NZ$17.06 Million16.29%
2021 -NZ$14.67 Million-907.36%
2020 NZ$1.81 M-106.6%
2019 -NZ$27.5 Million82.4%
2018 -NZ$15.08 Million-36.93%
2017 -NZ$23.91 Million-378.62%
2016 NZ$8.57 M-145.53%
2015 -NZ$18.85 Million369.37%
2014 -NZ$4.02 Million-125.9%
2013 NZ$15.49 M-177.74%
2012 -NZ$19.94 Million13.59%
2011 -NZ$17.56 Million74.37%
2010 -NZ$10.07 Million3.61%
2009 -NZ$9.72 Million
2007 -NZ$30.8 Million12.08%
2006 -NZ$27.48 Million-28.65%
2005 -NZ$38.51 Million-10.03%
2004 -NZ$42.81 Million-6.08%
2003 -NZ$45.58 Million-14.76%
2002 -NZ$53.47 Million32.52%
2001 -NZ$40.35 Million27.55%
2000 -NZ$31.64 Million62.5%
1999 -NZ$19.47 Million4.04%
1998 -NZ$18.72 Million49.33%
1997 -NZ$12.53 Million-27.88%
1996 -NZ$17.38 Million13.04%
1995 -NZ$15.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.12 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.31 B-583,059.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.21 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$43.67 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$20.06 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.43 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA